Bank of Montreal’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-63
Closed -$5.1K 4193
2024
Q1
$5.1K Hold
63
﹤0.01% 3740
2023
Q4
$5.99K Hold
63
﹤0.01% 3840
2023
Q3
$9.22K Hold
63
﹤0.01% 3634
2023
Q2
$11.3K Hold
63
﹤0.01% 3795
2023
Q1
$16.4K Sell
63
-3
-5% -$594 ﹤0.01% 3556
2022
Q4
$10.6K Hold
66
﹤0.01% 3769
2022
Q3
$21K Hold
66
﹤0.01% 3791
2022
Q2
$33K Hold
66
﹤0.01% 3694
2022
Q1
$28K Sell
66
-19
-22% -$9.69K ﹤0.01% 3882
2021
Q4
$16K Buy
+85
New +$23K ﹤0.01% 3367

Other funds holding EDVA

Bank of Montreal's EDVA Position: Q2 2024 in Review

Bank of Montreal sold out of Endovia Health Sciences, Inc. (EDVA) in Q2 2024, closing a stake of 63 shares — an estimated $5.1K sold.

Bank of Montreal first reported a position in EDVA in Q4 2021 and held it in 10 quarters. The position peaked at $33K in Q2 2022. 31 funds tracked by Wall St. Rank hold EDVA as of Q2 2024.

  • Bank of Montreal reported no remaining Endovia Health Sciences, Inc. position as of Q2 2024 after selling out during the quarter.
  • Bank of Montreal sold 63 Endovia Health Sciences, Inc. shares in Q2 2024, an estimated $5.1K.
  • Bank of Montreal first reported a position in Endovia Health Sciences, Inc. in Q4 2021 and held it in 10 quarters.
  • Bank of Montreal's Endovia Health Sciences, Inc. position peaked at $33K in Q2 2022.
  • 31 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q2 2024.

Based on Bank of Montreal's 13F filing for Q2 2024, filed 14 Aug 2024.